Last updated: 17 May 2024 at 4:45pm EST

Dennis Selkoe Net Worth




The estimated Net Worth of Dennis J. Selkoe is at least $358 Thousand dollars as of 3 July 2023. Dennis Selkoe owns over 5,000 units of Prothena plc stock worth over $164,196 and over the last 11 years he sold PRTA stock worth over $0. In addition, he makes $194,156 as Independent Director at Prothena plc.

Dennis Selkoe PRTA stock SEC Form 4 insiders trading

Dennis has made over 18 trades of the Prothena plc stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 5,000 units of PRTA stock worth $56,650 on 3 July 2023.

The largest trade he's ever made was exercising 15,000 units of Prothena plc stock on 3 May 2023 worth over $271,050. On average, Dennis trades about 2,790 units every 98 days since 2013. As of 3 July 2023 he still owns at least 7,845 units of Prothena plc stock.

You can see the complete history of Dennis Selkoe stock trades at the bottom of the page.





Dennis Selkoe biography

Dr. Dennis J. Selkoe M.D. serves as Independent Director of the Company. He is the Vincent and Stella Coates Professor of Neurologic Diseases at Harvard Medical School and co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital in Boston, positions he has held since 2000 and 1985, respectively. He has served on the faculty at Harvard Medical School since 1978. Dr. Selkoe was the principal founding scientist and served as a director of Athena Neurosciences, Inc. until it was acquired by Elan Corporation, plc in 1996. He hasreceived numerous honors, including the Mathilde Solowey Award in the Neurosciences (NIH), the Potamkin Prize (American Academy of Neurology), the A.H. Heineken Prize for Medicine (The Netherlands), the Pioneer Award and the Lifetime Achievement Award (Alzheimer’s Association), the George C. Cotzias Lecture of the American Academy of Neurology and the Ulysses Medal of University College Dublin. Dr. Selkoe is a Fellow of the American Academy of Neurology, the American Association for the Advancement of Science and the American College of Physicians, an elected member of the National Academy of Medicine and a director of the Foundation for Neurologic Diseases. He served as a director of Elan from 1996 to 2013. Dr. Selkoe earned his B.A. from Columbia University and his M.D. from the University of Virginia. He has served on our Board since 2013.

What is the salary of Dennis Selkoe?

As the Independent Director of Prothena plc, the total compensation of Dennis Selkoe at Prothena plc is $194,156. There are 14 executives at Prothena plc getting paid more, with Wagner Zago having the highest compensation of $3,341,640.



How old is Dennis Selkoe?

Dennis Selkoe is 76, he's been the Independent Director of Prothena plc since 2013. There are 1 older and 23 younger executives at Prothena plc. The oldest executive at Prothena Corporation plc is Christopher Henney, 78, who is the Independent Director.

What's Dennis Selkoe's mailing address?

Dennis's mailing address filed with the SEC is C/O PROTHENA BIOSCIENCES INC, 1800 SIERRA POINT PARKWAY, BRISBANE, CA, 94005.

Insiders trading at Prothena plc

Over the last 12 years, insiders at Prothena plc have traded over $79,429,035 worth of Prothena plc stock and bought 2,987,732 units worth $75,619,043 . The most active insiders traders include Capital, Llc Eco R1, Co Plc Elan Corp Plc Elan S..., and Helen Susan Kim. On average, Prothena plc executives and independent directors trade stock every 21 days with the average trade being worth of $946,769. The most recent stock trade was executed by Karin L Walker on 24 January 2024, trading 5,000 units of PRTA stock currently worth $67,650.



What does Prothena plc do?

prothena corporation plc (nasdaq: prta) is a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapy programs for the potential treatment of diseases that involve amyloid or cell adhesion. the company focuses on therapeutic monoclonal antibodies directed specifically to disease-causing proteins, and its antibody-based product candidates target a number of potential indications, including al amyloidosis (neod001), parkinson’s disease and other related synucleinopathies (prx002), and novel cell adhesion targets involved in psoriasis and other inflammatory diseases (prx003). our lead program, neod001, is in a global phase 3 registration clinical trial – the vital amyloidosis study. there is also an on-going phase 1/2 trial. prx002 is in a phase 1 multiple ascending dose clinical trial, and prx003 is in a phase 1 single ascending dose clinical trial. prothena’s elite team has a recognized track record both f



What does Prothena plc's logo look like?

Prothena Corporation plc logo

Complete history of Dennis Selkoe stock trades at Prothena plc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
3 Jul 2023 Dennis J. Selkoe
Option 5,000 $11.33 $56,650
3 Jul 2023
7,845
3 May 2023 Dennis J. Selkoe
Option 15,000 $18.07 $271,050
3 May 2023
17,845
3 Jan 2022 Dennis J. Selkoe
Option 5,000 $9.23 $46,150
3 Jan 2022
7,845
1 Oct 2021 Dennis J. Selkoe
Option 5,000 $9.23 $46,150
1 Oct 2021
7,845
30 Jul 2021 Dennis J. Selkoe
Option 5,000 $14.26 $71,300
30 Jul 2021
7,845
2 Oct 2017 Dennis J. Selkoe
Option 3,500 $16.42 $57,470
2 Oct 2017
6,345
7 Jul 2017 Dennis J. Selkoe
Option 3,500 $16.42 $57,470
7 Jul 2017
6,345
3 Apr 2017 Dennis J. Selkoe
Option 3,500 $16.42 $57,470
3 Apr 2017
6,345
1 Mar 2017 Dennis J. Selkoe
Option 3,500 $16.42 $57,470
1 Mar 2017
6,345
28 Nov 2016 Dennis J. Selkoe
Option 5,000 $16.42 $82,100
28 Nov 2016
7,845
22 Aug 2016 Dennis J. Selkoe
Option 5,000 $16.42 $82,100
22 Aug 2016
7,845
23 May 2016 Dennis J. Selkoe
Option 5,000 $16.42 $82,100
23 May 2016
7,665
4 Apr 2016 Dennis J. Selkoe
Option 5,000 $16.42 $82,100
4 Apr 2016
7,845
4 Apr 2016 Dennis J. Selkoe
Option 5,000 $16.42 $82,100
4 Apr 2016
7,845
1 Dec 2015 Dennis J. Selkoe
Option 3,125 $16.42 $51,313
1 Dec 2015
5,970
1 Sep 2015 Dennis J. Selkoe
Option 3,125 $16.42 $51,313
1 Sep 2015
5,970
1 Jun 2015 Dennis J. Selkoe
Option 3,125 $16.42 $51,313
1 Jun 2015
5,970
9 Mar 2015 Dennis J. Selkoe
Option 3,125 $16.42 $51,313
9 Mar 2015
5,970


Prothena plc executives and stock owners

Prothena plc executives and other stock owners filed with the SEC include: